Belldegrun Arie

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$27.71M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Belldegrun Arie

According to the SEC Form 4 filings, Belldegrun Arie, being in a position of

  1. director at Allogene Therapeutics, Inc.,
    оver the last 12 months, has bought 1724137 shares for $5M, and sold 0 shares,
    over all time since 2018-10-15, has bought 2560830 shares for $27.71M, and sold 0 shares.

The largest purchase of all time was on 2020-06-04 and amounted to 292764 shares of Allogene Therapeutics, Inc. for $13.76M.

Biography of Belldegrun Arie

No biography is available at this moment.

2024-05-16PurchaseAllogene Therapeutics, Inc.
ALLO
director
1.72M
0.9747%
$2.90$5M-12.33%
2022-01-12PurchaseAllogene Therapeutics, Inc.
ALLO
director
155,039
0.1121%
$12.60$1.95M-18.73%
2020-06-04PurchaseAllogene Therapeutics, Inc.
ALLO
director
292,764
0.2773%
$47.00$13.76M-19.63%
2018-10-15PurchaseAllogene Therapeutics, Inc.
ALLO
director
388,890
0.8969%
$18.00$7M+2.3%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.